Pura Vida Investments, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Pura Vida Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $913,292 - $1.6 Million	-10,985 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $11,008 - $14,291	100 Added 0.92%	10,985 $1.3 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $2.9 Million - $4.32 Million	-29,115 Reduced 72.79%	10,885 $1.5 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $373,800 - $494,700	10,000 Added 33.33%	40,000 $1.67 Million
Q1 2019 May 14, 2019	BUY	$34.52 - $53.29 $1.04 Million - $1.6 Million	30,000 New	30,000 $1.54 Million
Q2 2018 Aug 14, 2018	SELL	$23.62 - $42.29 $760,233 - $1.36 Million	-32,186 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$22.49 - $34.56 $224,899 - $345,600	-10,000 Reduced 23.7%	32,186 $0
Q4 2017 Feb 14, 2018	BUY	$20.44 - $35.56 $862,281 - $1.5 Million	42,186	42,186 $0

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.